Bernard Lo, MD
Internal Medicine · San Francisco
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 3
- 1 carrier
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lo’s office at (415) 353-4624 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G32367 · Delinquent
Licence status: Delinquent · since 1976 · expires 2025-12-31 · Stanford University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Original Medicare doctor bills
$4,331
Medicare paid this office $4,331 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 81 · Under 65 0% · Health risk score 1.18. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
The office billed $24,558, Medicare allowed $6,075 and paid $4,331; for 67 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 67 | 81 | 1.18 | $24,558 | $4,331 |
| 2023 | 17 | 94 | 79 | 1.34 | $41,991 | $6,686 |
| 2022 | 17 | 98 | 79 | 1.06 | $44,488 | $7,522 |
| 2021 | 20 | 70 | 77 | 1.18 | $34,604 | $5,859 |
| 2020 | 14 | 45 | 79 | 1.20 | $16,382 | $3,291 |
| 2019 | 21 | 48 | 79 | 1.02 | $29,338 | $3,358 |
| 2018 | 19 | 47 | 79 | 0.94 | $28,232 | $3,176 |
| 2017 | 19 | 40 | 77 | 0.90 | $21,292 | $2,425 |
| 2016 | 27 | 57 | 77 | 1.36 | $29,784 | $3,460 |
| 2015 | 22 | 56 | 77 | 1.36 | $28,302 | $3,740 |
| 2014 | 23 | 77 | 78 | 1.03 | $36,273 | $4,647 |
| 2013 | 21 | 65 | 78 | 1.18 | $28,260 | $3,878 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Long return visit (40+ min) | 15 | $2,738 | $110 |
2022: 1 service
| Long return visit (40+ min) | 13 | $3,335 | $119 |
2021: 2 services
| Long return visit (40+ min) | 12 | $2,253 | $125 |
| Return visit (30+ min) | 13 | $1,928 | $80 |
2019: 1 service
| Return visit (30+ min) | 15 | $1,664 | $64 |
2018: 2 services
| Long return visit (40+ min) | 12 | $1,819 | $91 |
| Return visit (30+ min) | 11 | $1,266 | $53 |
2017: 1 service
| Long return visit (40+ min) | 11 | $853 | $66 |
2016: 1 service
| Return visit (30+ min) | 15 | $1,917 | $60 |
2015: 1 service
| Return visit (30+ min) | 18 | $2,823 | $67 |
2014: 1 service
| Return visit (30+ min) | 20 | $3,512 | $66 |
2013: 1 service
| Return visit (30+ min) | 17 | $2,578 | $61 |
Drugs they prescribed that Part D paid
$21,104
Pharmacies billed $21,104 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
260 generic and fewer than 11 brand-name prescriptions · $21,104 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Valacyclovir | 13 | $950 | $73 |
| Atorvastatin | 21 | $384 | $18 |
| Benazepril | 11 | $255 | $23 |
| Omeprazole | 12 | $212 | $18 |
| Amlodipine Besylate | 19 | $142 | $7 |
See all 7 drugs
| Valacyclovir | 13 | $950 | $73 |
| Atorvastatin | 21 | $384 | $18 |
| Benazepril | 11 | $255 | $23 |
| Omeprazole | 12 | $212 | $18 |
| Amlodipine Besylate | 19 | $142 | $7 |
| Hydrochlorothiazide | 11 | $116 | $11 |
| Tamsulosin | 12 | $81 | $7 |
Year by year
| 2024 | 280 | 26 | None | None | $21,104 |
| 2023 | 342 | 29 | 5% (16) | None | $33,830 |
| 2022 | 344 | 28 | 5% (17) | None | $25,750 |
| 2021 | 280 | 26 | 8% (21) | None | $13,657 |
| 2020 | 311 | 27 | 8% (25) | None | $33,016 |
| 2019 | 263 | 27 | 7% (19) | None | $15,782 |
| 2018 | 279 | 25 | 7% (18) | 20% | $21,977 |
| 2017 | 283 | 27 | 5% (13) | 23% | $22,923 |
| 2016 | 349 | 34 | 4% (15) | 15% | $27,335 |
| 2015 | 447 | 31 | 3% (11) | None | $29,263 |
| 2014 | 509 | 37 | None | None | $35,482 |
| 2013 | 394 | 30 | None | None | $36,547 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Midodrine | 11 | $1,993 | $181 |
| Hydrocodone-Acetaminophen | 11 | $622 | $57 |
| Atorvastatin | 24 | $613 | $26 |
| Amlodipine Besylate | 20 | $397 | $20 |
| Benazepril | 15 | $295 | $20 |
| Omeprazole | 11 | $233 | $21 |
| Hydrochlorothiazide | 13 | $144 | $11 |
2022: 8 drugs
| Midodrine | 13 | $2,564 | $197 |
| Hydrocodone-Acetaminophen | 11 | $671 | $61 |
| Atorvastatin | 26 | $647 | $25 |
| Benazepril | 18 | $370 | $21 |
| Amlodipine Besylate | 19 | $362 | $19 |
| Lisinopril | 11 | $188 | $17 |
| Hydrochlorothiazide | 14 | $175 | $12 |
| Escitalopram | 11 | $67 | $6 |
2021: 7 drugs
| Hydrocodone-Acetaminophen | 15 | $578 | $39 |
| Atorvastatin | 24 | $395 | $16 |
| Levothyroxine | 11 | $342 | $31 |
| Amlodipine Besylate | 19 | $317 | $17 |
| Benazepril | 14 | $298 | $21 |
| Lisinopril | 11 | $145 | $13 |
| Warfarin | 11 | $53 | $5 |
2020: 6 drugs
| Hydrocodone-Acetaminophen | 21 | $755 | $36 |
| Atorvastatin | 33 | $584 | $18 |
| Amlodipine Besylate | 25 | $352 | $14 |
| Metformin | 11 | $290 | $26 |
| Lisinopril | 13 | $247 | $19 |
| Allopurinol | 12 | $225 | $19 |
2019: 6 drugs
| Silodosin | 11 | $592 | $54 |
| Atorvastatin | 22 | $537 | $24 |
| Lisinopril | 13 | $221 | $17 |
| Allopurinol | 12 | $216 | $18 |
| Amlodipine Besylate | 23 | $176 | $8 |
| Hydrochlorothiazide | 15 | $46 | $3 |
2018: 6 drugs
| Atorvastatin | 26 | $734 | $28 |
| Omeprazole | 16 | $273 | $17 |
| Levothyroxine | 12 | $216 | $18 |
| Montelukast | 11 | $69 | $6 |
| Amlodipine Besylate | 12 | $51 | $4 |
| Losartan | 11 | $50 | $5 |
2017: 10 drugs
| Serevent Diskus | 18 | $9,808 | $545 |
| Qvar | 18 | $4,428 | $246 |
| Levothyroxine | 22 | $475 | $22 |
| Dilt-Xr | 13 | $384 | $30 |
| Atorvastatin | 26 | $381 | $15 |
| Lisinopril | 14 | $117 | $8 |
| Amlodipine Besylate | 20 | $94 | $5 |
| Montelukast | 13 | $67 | $5 |
| Hydrochlorothiazide | 20 | $48 | $2 |
| Losartan | 13 | $37 | $3 |
2016: 14 drugs
| Serevent Diskus | 11 | $6,099 | $554 |
| Qvar | 13 | $4,148 | $319 |
| Levothyroxine | 19 | $391 | $21 |
| Atorvastatin | 21 | $348 | $17 |
| Dilt-Xr | 12 | $329 | $27 |
| Omeprazole | 16 | $285 | $18 |
| Montelukast | 12 | $176 | $15 |
| Lisinopril | 12 | $162 | $14 |
| Finasteride | 18 | $153 | $9 |
| Amlodipine Besylate | 18 | $135 | $7 |
| Ranitidine | 11 | $128 | $12 |
| Metoprolol | 12 | $70 | $6 |
| Hydrochlorothiazide | 20 | $58 | $3 |
| Losartan | 15 | $48 | $3 |
2015: 10 drugs
| Atorvastatin | 36 | $666 | $19 |
| Levothyroxine | 17 | $655 | $39 |
| Valacyclovir | 12 | $369 | $31 |
| Omeprazole | 12 | $219 | $18 |
| Pantoprazole | 17 | $207 | $12 |
| Finasteride | 23 | $194 | $8 |
| Warfarin | 16 | $184 | $11 |
| Hydrochlorothiazide | 33 | $150 | $5 |
| Amlodipine Besylate | 22 | $135 | $6 |
| Lisinopril | 14 | $104 | $7 |
2014: 11 drugs
| Diovan | 11 | $3,011 | $274 |
| Atorvastatin | 44 | $1,061 | $24 |
| Valacyclovir | 16 | $900 | $56 |
| Levothyroxine | 16 | $355 | $22 |
| Warfarin | 29 | $237 | $8 |
| Pantoprazole | 15 | $234 | $16 |
| Amlodipine Besylate | 27 | $233 | $9 |
| Finasteride | 19 | $193 | $10 |
| Hydrochlorothiazide | 30 | $191 | $6 |
| Naproxen | 15 | $148 | $10 |
| Simvastatin | 15 | $117 | $8 |
2013: 10 drugs
| Montelukast | 12 | $1,657 | $138 |
| Atorvastatin | 34 | $1,570 | $46 |
| Amlodipine Besylate | 23 | $659 | $29 |
| Valacyclovir | 12 | $483 | $40 |
| Warfarin | 15 | $355 | $24 |
| Lovastatin | 13 | $284 | $22 |
| Alendronate | 17 | $200 | $12 |
| Allopurinol | 12 | $135 | $11 |
| Citalopram Hbr | 16 | $108 | $7 |
| Atenolol | 15 | $96 | $6 |
Money from drug and device companies
$24,727 in 2025
| 2025 | 1 | 28 | $20,425 | $24,727 |
| 2024 | 1 | 3 | $15,821 | $15,821 |
| 2023 | 1 | 18 | $14,315 | $16,413 |
| 2022 | 1 | 13 | $12,400 | $14,215 |
| 2021 | 1 | 12 | $10,720 | $11,525 |
| 2020 | 1 | 2 | $4,500 | $4,500 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Takeda Pharmaceuticals U.S.A. | None | $24,727 | 28 payments
|
See all 28 published payments
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-12-09 | None | $360 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-09-26 | None | $8,788 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-26 | None | $12 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-26 | None | $16 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-26 | None | $22 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-09-26 | None | $114 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-09-26 | None | $567 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-25 | None | $16 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-25 | None | $35 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-25 | None | $96 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-09-25 | None | $250 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-09-25 | None | $405 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-09-24 | None | $405 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-08-21 | None | $5,225 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-07-21 | None | $300 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-30 | None | $7 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-30 | None | $19 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-30 | None | $31 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-05-30 | None | $358 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-05-30 | None | $616 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-29 | None | $10 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-29 | None | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-29 | None | $34 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-29 | None | $128 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-05-29 | None | $358 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2025-05-28 | None | $125 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-03-14 | None | $2,850 |
| Takeda Pharmaceuticals U.S.A. | Consulting · 2025-02-27 | None | $3,563 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $15,821
| Takeda Pharmaceuticals U.S.A. | None | $15,821 | 3 payments
|
2023: $16,413
| Takeda Pharmaceuticals U.S.A. | None | $16,413 | 18 payments
|
2022: $14,215
| Takeda Pharmaceuticals U.S.A. | None | $14,215 | 13 payments
|
2021: $11,525
| Takeda Pharmaceuticals U.S.A. | None | $11,525 | 12 payments
|
2020: $4,500
| Takeda Pharmaceuticals U.S.A. | None | $4,500 | 2 payments
|
Professional record
- NPI
- 1184688137
- Licence
- CA G32367California G32367: Delinquent · expires 2025-12-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 0G3236700
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1635 Divisadero Street, Suite 625, Box 1821, San Francisco, CA, 94143
- NPI first listed
- 2006-04-14
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.